<DOC>
	<DOCNO>NCT02522949</DOCNO>
	<brief_summary>This study evaluate performance ColdZyme® mouth spray prevention alleviation induce rhinovirus upper respiratory tract infection healthy volunteer . Half participant receive ColdZyme® mouth spray half receive placebo .</brief_summary>
	<brief_title>Evaluation ColdZyme® Mouth Spray Prevention Alleviation Rhinovirus Induced Common Cold</brief_title>
	<detailed_description>Common cold cause number virus , e.g . rhinovirus , coronaviruses , influenza viruses others . The majority colds however cause rhinovirus infection , responsible 80 % common cold . This study evaluate effect create physical barrier pharyngeal mucosal membrane prevent reduce virus cell entry common cold infection reduce total virus load common cold symptom vivo relation placebo .</detailed_description>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Common Cold</mesh_term>
	<criteria>1 . Healthy male female subject 1865 year . The investigator judge definition healthy detailed medical history physical examination . 2 . Females childbearing potential : use reliable method birth control . Reliable method hormonal contraceptive ( combination pill , injection implant ) , intrauterine device , condom declare absence sexual contact . Postmenopausal woman define absence menstrual discharge least two year . 3 . Signed informed consent form prior studyrelated procedure . 4 . Willingness ability complete study . 5 . Perceived least one cold per year . 1 . Smoker , last 12 month . 2 . Any cold symptom within last month sore throat , sneeze , rhinorrhoea , malaise , nasal obstruction cough . 3 . Presence serum neutralise antibody human rhinovirus16 screening . 4 . Active allergic rhinitis , asthma chronic obstructive pulmonary disease last year . 5 . Positive fur allergy ( subject likely come contact specific pet ) and/or dustmite allergy skin prick test screening . 6 . Nasal disease , e.g . nasal polyposis , significant septal deviation , chronic rhinosinusitis , etc . 7 . Females : Pregnant , breastfeed intention become pregnant study . 8 . Active autoimmune disease last year . 9 . Evidence history drug alcohol abuse . 10 . Use prescribed nonprescribed medication ( except contraceptive , paracetamol ibuprofen ) within 2 week prior first administration investigational product end study . 11 . Use counter cold prophylaxis product Cvitamins , zinc Echinacea within 1 month prior first administration investigational product end study . 12 . Participation clinical study within 60 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>